SMAD2 and rheumatoid arthritis: Firstly, we observed downregulation of anti-inflammatory genes such as SMAD2 and SOCS1 that downregulates inflammatory cytokine secretion by inhibiting JAK/STAT pathway in patients with RA, but not during early disease stages.